NAS114

N/A

Report date: 2023/06/14 17:45:45
NME

Base Information

Drug NameNAS114
Drug Alias NameAEOL-11114BAEOL11114AEOL-11114NAS114NAS-114
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase modulators
TargetsSuperoxide dismutase
Therapy Area/IndicationsNerve DegenerationParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Colorado Anschutz Medical CampusNational Jewish Medical and Research Center
China Registration ClassN/A

Develop Information

Active CompaniesNew Amsterdam Sciences Inc
Inactive CompaniesNational Jewish Medical and Research CenterUniversity of Colorado Anschutz Medical Campus
Active IndicationsNerve Degeneration
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A